Koninklijke Philips (PHG) Net Shares Issued and Repurchased (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Net Shares Issued and Repurchased of -$79.0 million for Q2 2026, up 82.0% quarter-over-quarter from -$439.2 million in Q4 2024.
Koninklijke Philips (PHG) Net Shares Issued and Repurchased (2009 - 2026) Analysis & Trends
Koninklijke Philips' Net Shares Issued and Repurchased history runs 13 years deep, the most recent figure standing at -$79.0 million for Q2 2026.
- In Q2 2026, Net Shares Issued and Repurchased changed N/A year-over-year to -$79.0 million; the TTM figure through Jun 2026 stood at -$1.0 billion (changed N/A YoY), while the FY2024 annual figure was -$439.2 million, up 38.34% from the prior year.
- Net Shares Issued and Repurchased for Q2 2026 stood at -$79.0 million, up from -$439.2 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was -$50.2 million in Q2 2022, with the low at -$712.3 million in Q4 2023.
- The 4-year median for Net Shares Issued and Repurchased is -$190.8 million (2022), against an average of -$243.3 million.
- The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased jumped 89.81% in 2022, then tumbled 273.34% in 2023.
- Koninklijke Philips' Net Shares Issued and Repurchased stood at -$190.8 million in 2022, then sank by 273.34% to -$712.3 million in 2023, then soared by 38.34% to -$439.2 million in 2024, then jumped by 82.0% to -$79.0 million in 2026.
- Business Quant data shows PHG's Net Shares Issued and Repurchased at -$79.0 million in Q2 2026, -$439.2 million in Q4 2024, and -$294.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -79.04 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -79.04 Mn |
| Jun 30, 2026 | -79.04 Mn |
| Dec 31, 2024 | -439.19 Mn |
| Dec 31, 2024 | -439.19 Mn |
| Sep 30, 2024 | -294.32 Mn |
| Sep 30, 2024 | -294.32 Mn |
| Jun 30, 2024 | -223.99 Mn |
| Jun 30, 2024 | -223.99 Mn |
| Mar 31, 2024 | -103.20 Mn |
| Mar 31, 2024 | -103.20 Mn |
| Dec 31, 2023 | -712.27 Mn |
| Dec 31, 2023 | -712.27 Mn |
| Jun 30, 2023 | -96.91 Mn |
| Jun 30, 2023 | -96.91 Mn |
| Dec 31, 2022 | -190.79 Mn |
| Dec 31, 2022 | -190.79 Mn |
| Jun 30, 2022 | -50.15 Mn |
| Jun 30, 2022 | -50.15 Mn |
| Dec 31, 2021 | -1.87 Bn |
| Dec 31, 2021 | -1.87 Bn |